{"database": "lobbying", "table": "lobbying_activities", "rows": [[2026617, "982a1f56-98cf-40aa-a9ae-2e7612a47fab", "Q3", "THE SMITH-FREE GROUP, LLC", 35800, "BALLANTYNE BRANDS LLC", 2017, "third_quarter", "TOB", "H.R. 1136 - FDA Deeming Authority Clarification Act of 2017 (All sections of full text)\n\nFDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding \"Intended Uses\" (All Sections of full text)\n\nFDA Implementation of P.L. 11-31 (All sections of full text)", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-17T11:05:52.537000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2026617"], "units": {}, "query_ms": 0.696418050210923, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}